DK174892B1 - Anvendelse af en kombination af ethinyløstradiol og norethindronacetat til fremstilling af et farmaceutisk præparat til behandling af osteoporosis - Google Patents

Anvendelse af en kombination af ethinyløstradiol og norethindronacetat til fremstilling af et farmaceutisk præparat til behandling af osteoporosis Download PDF

Info

Publication number
DK174892B1
DK174892B1 DK198700999A DK99987A DK174892B1 DK 174892 B1 DK174892 B1 DK 174892B1 DK 198700999 A DK198700999 A DK 198700999A DK 99987 A DK99987 A DK 99987A DK 174892 B1 DK174892 B1 DK 174892B1
Authority
DK
Denmark
Prior art keywords
approx
osteoporosis
combination
treatment
norethindrone acetate
Prior art date
Application number
DK198700999A
Other languages
Danish (da)
English (en)
Other versions
DK99987A (da
DK99987D0 (da
Inventor
Roger Boissoneault
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of DK99987D0 publication Critical patent/DK99987D0/da
Publication of DK99987A publication Critical patent/DK99987A/da
Application granted granted Critical
Publication of DK174892B1 publication Critical patent/DK174892B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Dental Preparations (AREA)
DK198700999A 1986-02-27 1987-02-26 Anvendelse af en kombination af ethinyløstradiol og norethindronacetat til fremstilling af et farmaceutisk præparat til behandling af osteoporosis DK174892B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83426386A 1986-02-27 1986-02-27
US83426386 1986-02-27

Publications (3)

Publication Number Publication Date
DK99987D0 DK99987D0 (da) 1987-02-26
DK99987A DK99987A (da) 1987-08-28
DK174892B1 true DK174892B1 (da) 2004-01-26

Family

ID=25266516

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198700999A DK174892B1 (da) 1986-02-27 1987-02-26 Anvendelse af en kombination af ethinyløstradiol og norethindronacetat til fremstilling af et farmaceutisk præparat til behandling af osteoporosis

Country Status (12)

Country Link
EP (1) EP0235090B1 (ja)
JP (1) JP2942560B2 (ja)
AT (1) ATE94392T1 (ja)
AU (1) AU599082B2 (ja)
CA (1) CA1300017C (ja)
DE (1) DE3787386T2 (ja)
DK (1) DK174892B1 (ja)
ES (1) ES2059403T3 (ja)
HK (1) HK182795A (ja)
MY (1) MY101855A (ja)
NL (1) NL300004I1 (ja)
ZA (1) ZA87332B (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK174724B1 (da) † 1986-07-15 2003-10-06 Wyeth Corp Anvendelse af et præparat omfattende et østrogen og et progestogen til fremstilling af en dosisform til tilvejebringelse af hormonerstatningsterapi og kontraception til kvinder i præmenopausen samt pakning til tilvejebringelse af præparatet
HUT52382A (en) * 1988-03-14 1990-07-28 Sandoz Ag Process for producing pharmaceutical compositions comprising as active ingredient unsubstituted progestin in 19-position and estrogen in the given case
US4973468A (en) * 1989-03-22 1990-11-27 Cygnus Research Corporation Skin permeation enhancer compositions
US5059426A (en) * 1989-03-22 1991-10-22 Cygnus Therapeutic Systems Skin permeation enhancer compositions, and methods and transdermal systems associated therewith
US5053227A (en) * 1989-03-22 1991-10-01 Cygnus Therapeutic Systems Skin permeation enhancer compositions, and methods and transdermal systems associated therewith
AU640112B2 (en) * 1989-11-03 1993-08-19 Warner-Lambert Company Estrogen and progestogen containing oral dosage forms
US5591753A (en) * 1994-01-28 1997-01-07 Eli Lilly And Company Combination treatment for osteoporosis
FR2754179B1 (fr) 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
WO2001030356A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU582540B2 (en) * 1983-08-05 1989-04-06 Pre Jay Holdings Ltd. A method of hormonal treatment of perimenopausal, menopausal and post-menopausal disorders and multi-preparation pack therefor

Also Published As

Publication number Publication date
AU599082B2 (en) 1990-07-12
EP0235090B1 (en) 1993-09-15
DE3787386T2 (de) 1994-05-05
ZA87332B (en) 1987-08-26
MY101855A (en) 1992-01-31
DK99987A (da) 1987-08-28
DE3787386D1 (de) 1993-10-21
ATE94392T1 (de) 1993-10-15
NL300004I1 (nl) 2000-04-03
AU6913087A (en) 1987-09-03
HK182795A (en) 1995-12-08
JP2942560B2 (ja) 1999-08-30
JPS62205024A (ja) 1987-09-09
EP0235090A1 (en) 1987-09-02
ES2059403T3 (es) 1994-11-16
DK99987D0 (da) 1987-02-26
CA1300017C (en) 1992-05-05

Similar Documents

Publication Publication Date Title
EP0402950B1 (en) Treatment of postmenopausal disorders
KR100369206B1 (ko) 에스트로겐및게스타겐함유피임용조성물
US4425339A (en) Treatment of menopausal symptoms
DK174071B1 (da) Kontraceptivt præparat i form af en pakning omfattende enhedsdoser
US5280023A (en) Ovulation-inhibiting preparation for hormonal contraception
EP0253607B2 (en) Combination dosage form for premenopausal women
AU678150B2 (en) Estrogen/progestin/antiprogestin method and kit for oral contraception and regulating menses
KR100352571B1 (ko) 배합호르몬피임약제
JPH04290828A (ja) 低エストロゲン経口避妊薬
PL186339B1 (pl) Wieloskładnikowy hormonalny preparat antykoncepcyjny na bazie naturalnego estrogenu
DK174892B1 (da) Anvendelse af en kombination af ethinyløstradiol og norethindronacetat til fremstilling af et farmaceutisk præparat til behandling af osteoporosis
JPH11503440A (ja) ホルモン避妊用医薬の複合調剤
JP2002509524A (ja) エストロゲン化合物とプロゲステロン様化合物よりなるホルモン組成物
EP0322020A1 (en) Pharmaceutical dosage unit for treating climacteric complaints and osteoporosis
AU747710B2 (en) Progestogen-antiprogestogen regimens
AU640112B2 (en) Estrogen and progestogen containing oral dosage forms
CA2134961C (en) Estrogen/progestin/antiprogestin method and kit for oral contraception and regulating menses
DK174181B1 (da) Farmaceutisk præparat til hormonbehandling
MXPA00004610A (en) Progestogen-antiprogestogen regimens

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK